Ramzi Dagher

3.4k total citations · 1 hit paper
39 papers, 2.6k citations indexed

About

Ramzi Dagher is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Ramzi Dagher has authored 39 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 7 papers in Hematology. Recurrent topics in Ramzi Dagher's work include Cancer Treatment and Pharmacology (5 papers), Statistical Methods in Clinical Trials (4 papers) and Renal cell carcinoma treatment (3 papers). Ramzi Dagher is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Statistical Methods in Clinical Trials (4 papers) and Renal cell carcinoma treatment (3 papers). Ramzi Dagher collaborates with scholars based in United States, Japan and Canada. Ramzi Dagher's co-authors include Richard Pazdur, Lee J. Helman, Robert Justice, Rajeshwari Sridhara, Ann T. Farrell, Brian Booth, David E. Morse, Sophia Abraham, Robert C. Kane and Edwin P. Rock and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Ramzi Dagher

39 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Approval Summary: Sunitinib for the Treatment of Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors and Advanced Renal Cell Carcinoma

2007 407 citations Ramzi Dagher, Sophia Abraham et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ramzi Dagher United States	24	982	848	656	449	290	39	2.6k
Jacques‐Olivier Bay France	25	702 0.7×	721 0.9×	538 0.8×	891 2.0×	290 1.0×	151	2.4k
John Hilton Canada	25	828 0.8×	1.2k 1.5×	616 0.9×	421 0.9×	111 0.4×	162	2.6k
Barbara L. Asselin United States	37	690 0.7×	1.1k 1.3×	605 0.9×	873 1.9×	481 1.7×	83	5.1k
Ronald G. Stoller United States	27	920 0.9×	2.0k 2.4×	535 0.8×	568 1.3×	268 0.9×	63	3.5k
Paul Noordhuis Netherlands	32	1.4k 1.4×	1.7k 2.0×	506 0.8×	340 0.8×	237 0.8×	82	3.4k
Erdem Göker Türkiye	25	752 0.8×	1.1k 1.3×	932 1.4×	308 0.7×	139 0.5×	99	2.5k
Gwen Nichols United States	24	1.1k 1.2×	1.1k 1.3×	325 0.5×	504 1.1×	271 0.9×	63	2.4k
Glenn Mills United States	26	673 0.7×	1.9k 2.2×	930 1.4×	428 1.0×	570 2.0×	119	3.4k
Robert C. Kane United States	22	1.4k 1.4×	1.1k 1.3×	434 0.7×	628 1.4×	310 1.1×	32	3.0k
Samuel A. Jacobs United States	25	620 0.6×	1.4k 1.7×	450 0.7×	279 0.6×	753 2.6×	143	2.9k

Countries citing papers authored by Ramzi Dagher

Since Specialization

Citations

This map shows the geographic impact of Ramzi Dagher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramzi Dagher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramzi Dagher more than expected).

Fields of papers citing papers by Ramzi Dagher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramzi Dagher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramzi Dagher. The network helps show where Ramzi Dagher may publish in the future.

Co-authorship network of co-authors of Ramzi Dagher

This figure shows the co-authorship network connecting the top 25 collaborators of Ramzi Dagher. A scholar is included among the top collaborators of Ramzi Dagher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramzi Dagher. Ramzi Dagher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Wolter, Kevin D., et al.. (2024). A Sponsor’s Perspective on the Contribution of Regulatory-Required Observational Post-Marketing Studies to Understanding Human Drug Product Benefit/Risk in Japan. Pharmaceutical Medicine. 38(3). 217–224. 1 indexed citations

2.

Koehler, María, et al.. (2016). Pragmatic randomized clinical trials: a proposal to enhance evaluation of new cancer therapies with early signs of exceptional activity. Annals of Oncology. 27(7). 1342–1348. 13 indexed citations

3.

Flannery, Carl R., Nicholas Moran, Dominick J. Blasioli, et al.. (2015). Efficacy of a novel, locally delivered TrkA inhibitor in preclinical models of OA and joint pain. Osteoarthritis and Cartilage. 23. A45–A46. 11 indexed citations

4.

Dagher, Ramzi, et al.. (2015). The Relationship Between Development Start Lag and Approval Lag in Oncology Drug Development in Japan. Therapeutic Innovation & Regulatory Science. 49(6). 911–919. 10 indexed citations

5.

Fox, Elizabeth, Brigitte C. Widemann, Douglas S. Hawkins, et al.. (2009). Randomized Trial and Pharmacokinetic Study of Pegfilgrastim versus Filgrastim after Dose-Intensive Chemotherapy in Young Adults and Children with Sarcomas. Clinical Cancer Research. 15(23). 7361–7367. 33 indexed citations

6.

Dagher, Ramzi, et al.. (2008). Good Clinical Practice and the Conduct of Clinical Studies in Pediatric Oncology. Pediatric Clinics of North America. 55(1). 187–209. 10 indexed citations

7.

Booth, Brian, Atiqur Rahman, Ramzi Dagher, et al.. (2006). Population Pharmacokinetic–Based Dosing of Intravenous Busulfan in Pediatric Patients. The Journal of Clinical Pharmacology. 47(1). 101–111. 74 indexed citations

8.

Brave, Michael H., Ramzi Dagher, Ann Farrell, et al.. (2006). Topotecan in combination with cisplatin for the treatment of stage IVB, recurrent, or persistent cervical cancer.. PubMed. 20(11). 1401–4, 1410; discussion 1410. 37 indexed citations

9.

Barker, Robert H., Ramzi Dagher, David M. Davidson, & Judith K. Marquis. (2006). Review article: tolevamer, a novel toxin‐binding polymer: overview of preclinical pharmacology and physicochemical properties. Alimentary Pharmacology & Therapeutics. 24(11-12). 1525–1534. 32 indexed citations

10.

Dagher, Ramzi & Richard Pazdur. (2006). The Role of FDA in the Regulation of Anti-Cancer Drugs. Current Cancer Therapy Reviews. 2(4). 327–329. 1 indexed citations

11.

Farrell, Ann T., et al.. (2005). The advisory process for anticancer drug regulation: a global perspective. Annals of Oncology. 17(6). 889–896. 16 indexed citations

12.

Dagher, Ramzi, John R. Johnson, Grant Williams, Patricia Keegan, & Richard Pazdur. (2004). Accelerated Approval of Oncology Products: A Decade of Experience. JNCI Journal of the National Cancer Institute. 96(20). 1500–1509. 60 indexed citations

13.

Dagher, Ramzi, Lauren Long, Elizabeth J. Read, et al.. (2002). Pilot trial of tumor‐specific peptide vaccination and continuous infusion interleukin‐2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: An inter‐institute NIH study†. Medical and Pediatric Oncology. 38(3). 158–164. 118 indexed citations

14.

Cohen, Martin H., Ramzi Dagher, Donna Griebel, et al.. (2002). U.S. Food and Drug Administration Drug Approval Summaries: Imatinib Mesylate, Mesna Tablets, and Zoledronic Acid. The Oncologist. 7(5). 393–400. 42 indexed citations

15.

Dagher, Ramzi, Thu Pham, Lynn Sorbara, et al.. (2001). Molecular Confirmation of Ewing Sarcoma. The American journal of pediatric hematology/oncology. 23(4). 221–224. 44 indexed citations

16.

Orschell-Traycoff, Christie M., Kelly Hiatt, Ramzi Dagher, et al.. (2000). Homing and engraftment potential of Sca-1+lin− cells fractionated on the basis of adhesion molecule expression and position in cell cycle. Blood. 96(4). 1380–1387. 107 indexed citations

17.

Orschell-Traycoff, Christie M., Kelly Hiatt, Ramzi Dagher, et al.. (2000). Homing and engraftment potential of Sca-1+lin− cells fractionated on the basis of adhesion molecule expression and position in cell cycle. Blood. 96(4). 1380–1387. 2 indexed citations

18.

Dagher, Ramzi, Susan G. Kreissman, Kent A. Robertson, et al.. (1998). High Dose Chemotherapy With Autologous Peripheral Blood Progenitor Cell Transplantation in an Anephric Child With Multiply Recurrent Wilms Tumor. Journal of Pediatric Hematology/Oncology. 20(4). 357–360. 12 indexed citations

19.

Dagher, Ramzi, et al.. (1998). c-Kit and CD38 are expressed by long-term reconstituting hematopoietic cells present in the murine yolk sac. Biology of Blood and Marrow Transplantation. 4(2). 69–74. 23 indexed citations

20.

Dagher, Ramzi, et al.. (1997). Outpatient total body irradiation for pediatric patients undergoing stem cell transplantation. Bone Marrow Transplantation. 19(11). 1065–1067. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact